Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.439
-0.020 (-4.30%)
Mar 9, 2026, 2:20 PM EDT - Market open
Klotho Neurosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 4.49 | 2.89 | 0.63 | 0.57 | 0.29 | 0.17 | |
| Operating Expenses | 7.18 | 5.54 | 0.63 | 0.57 | 1.11 | 0.91 | |
| Operating Income | -7.18 | -5.54 | -0.63 | -0.57 | -1.11 | -0.91 | |
| Interest Expense | -3.79 | -0.36 | -0.08 | -0.02 | - | - | |
| Interest & Investment Income | - | - | - | - | - | 0 | |
| Other Non Operating Income (Expenses) | 0.13 | -0.25 | 0 | 0 | 0 | - | |
| EBT Excluding Unusual Items | -10.84 | -6.15 | -0.71 | -0.6 | -1.11 | -0.91 | |
| Pretax Income | -11.29 | -6.15 | -0.71 | -0.6 | -1.11 | -0.91 | |
| Earnings From Continuing Operations | -11.29 | -6.15 | -0.71 | -0.6 | -1.11 | -0.91 | |
| Net Income | -11.29 | -6.15 | -0.71 | -0.6 | -1.11 | -0.91 | |
| Net Income to Common | -11.29 | -6.15 | -0.71 | -0.6 | -1.11 | -0.91 | |
| Shares Outstanding (Basic) | 37 | 19 | 15 | 1,045 | 172 | - | |
| Shares Outstanding (Diluted) | 37 | 19 | 15 | 1,045 | 172 | - | |
| Shares Change (YoY) | 128.77% | 27.21% | -98.55% | 508.33% | - | - | |
| EPS (Basic) | -0.30 | -0.32 | -0.05 | -0.00 | -0.01 | - | |
| EPS (Diluted) | -0.30 | -0.32 | -0.05 | -0.00 | -0.01 | - | |
| EBIT | -7.18 | -5.54 | -0.63 | -0.57 | -1.11 | -0.91 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.